Edesa Biotech, Inc. (EDSA) Total liabilities 2013–2021
Edesa Biotech, Inc. (EDSA) total liabilities at each fiscal year-end, per SEC filings.
$1.5MFY2021 · since FY2013: $10.7M → $1.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $1.5M | -7.7% |
| FY2020 | $1.7M | — |
| FY2018 | $183,820 | -42.7% |
| FY2017 | $320,947 | -48.5% |
| FY2016 | $623,644 | -73.8% |
| FY2015 | $2.4M | -64.9% |
| FY2014 | $6.8M | -36.8% |
| FY2013 | $10.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice